Alpha 1 -adrenoceptor expression on nociceptors may play an important role in sympathetic-sensory coupling in certain neuropathic pain syndromes. The aim of this study was to determine whether α 1 -adrenoceptor expression was up-regulated on surviving peptidergic, non-peptidergic and myelinated nerve fiber populations in the skin after chronic constriction injury of the sciatic nerve in rats. Seven days after surgery, α 1 -adrenoceptor expression was up-regulated in the epidermis and on dermal nerve fibres in plantar skin ipsilateral to the injury, but not around blood vessels. This α 1 -adrenoceptor up-regulation in the plantar skin was observed on all nerve fiber populations examined. However, α 1 -adrenoceptor expression was unaltered in dorsal hind paw skin after the injury. The increased expression of α 1 -adrenoceptors on cutaneous nociceptors in plantar skin after chronic constriction injury suggests that this may be a site of sensory-sympathetic coupling that increases sensitivity to adrenergic agonists after nerve injury. In addition, activation of up-regulated α 1 -adrenoceptors in the epidermis might cause release of factors that stimulate nociceptive signalling.
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Activation of the sympathetic nervous system with consequent release of norepinephrine does not normally activate nociceptors. However, after injury, sensory-sympathetic coupling in the skin may become a source of pain by activating α 1 -adrenoceptors (α 1 -ARs) on nociceptive afferent fibers 1, 10, 12, 28, 43 . After nerve injury, messenger RNA for the α 1B -AR subtype increases in the dorsal root ganglia 29, 50 , but whether this results in an up-regulation of α 1 -ARs on nociceptors in the skin is unknown.
Chronic constriction injury (CCI) of the rat sciatic nerve triggers signs of pain and hyperalgesia as early as 24 hours post-injury 3, 5, 9, 18 , together with neurodegeneration of sensory nerve fibers in the injured sciatic nerve and the skin. The injured nerve fibers regenerate gradually in the weeks following injury, resulting in a de novo, spatially intimate association of sprouting sympathetic efferent fibers and sensory afferent fibers in the upper dermis 25-27, 37, 51 . Chemical and surgical sympathectomy generally attenuates allodynia and thermal hyperalgesia after CCI 7, 34 (but see 18 ),
suggesting that certain features of the neuropathic pain associated with CCI may be sympathetically maintained. Therefore, the aim of this study was to determine whether α 1 -AR expression was upregulated on surviving peptidergic, non-peptidergic and myelinated nerve fiber populations in the skin after CCI. As α 1 -AR expression in the epidermis and on blood vessels could indirectly influence nociceptor signalling, α 1 -AR expression changes on these skin structures were also examined.
Methods

Chronic constriction injury
The experiments conformed to the ethical guidelines of the International Association for the Study Dawley rats weighing 175-200g. Six rats underwent unilateral CCI of the common sciatic nerve 5 and three rats were examined as naive, un-operated age-matched controls.
Histological processing and immunohistochemsitry
Seven days after surgery rats were anesthetised with a lethal dose of sodium pentobarbital (100 mg/kg, IP) and perfused transcardially with a vascular rinse (0.1M phosphate buffered saline containing 0.05% sodium bicarbonate and 0.1% sodium nitrite) followed by freshly prepared 4% paraformaldehyde in 0.1M phosphate buffered saline (PBS), pH 7.4. The hind paws were severed and post-fixed overnight, after which a sample of glabrous, plantar skin was excised from the wide part of the plantar hind paw that lies distal to the calcaneus and proximal to the digital tori and another sample of skin was taken from the dorsum of the hind paw proximal to the toes. The samples were cryoprotected in 30% sucrose at 4°C overnight and then embedded in Optimal Cutting
Temperature compound, frozen on dry ice, and stored at -80°C. 10 µm thick cross-sections were cut using a cryostat and collected onto silane coated slides (Hurst Scientific).
Cryosections were stained with the following combinations of antibodies (details shown in Table 1 ): α 1 -AR/calcitonin gene related peptide (CGRP)/pan-neuronal marker (TUJ1) to examine α 1 -AR expression on peptidergic afferents; α 1 -AR/isolectin B4 (IB4)/TUJ1 to examine α 1 -AR expression on non-peptidergic afferents; α 1 -AR/neurofilament 200 (NF200)/TUJ1 to examine α 1 -AR expression on myelinated fibers; and α 1 -AR/smooth muscle actin (SMA) to examine α 1 -AR expression on blood vessels.
For immunohistochemistry, sections initially were washed in 0.1M PBS (3x10 min) and then incubated with 0.2% Triton X-100 for 7.5 min at room temperature. Sections were washed with PBS (3x5 min) and blocked for 2 hrs in 10% donkey serum in PBS at room temperature. Sections were incubated for 48 hrs at 4°C with primary antibodies using the concentrations shown in Table 1 , diluted in blocking solution. Sections were washed with PBS (3x15 min) and then incubated with the M A N U S C R I P T
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5 appropriate secondary antibodies diluted in 5% donkey serum (Sigma) in PBS for 4 hrs at room temperature. Sections were washed with PBS (3x15 min) and cover-slipped with Prolong Gold antifade mounting media.
The peptide sequence recognized by the α 1 -AR antibody used in this study is unique to the α 1 -AR, a G-protein-coupled receptor (National Center for Biotechnology Information, National Institutes of Health, BLAST program, http://blast.ncbi.nlm.nih.gov/Blast.cgi). In an examination of the specificity of the α 1 -AR antibody, the pattern of staining on blood vessels, nerves and epidermal cells in rat skin tissue resembled the staining pattern produced by BODIPY FL-prazosin, a fluorescent α 1 -AR antagonist. 6 In addition, staining was eliminated following pre-adsorption of the anti-sera with an α 1 -AR-specific peptide. 6 In the present study, no staining was observed on negative control sections that had the primary antibodies omitted. Two consecutive sections per sample were stained with a combination of antibodies, and immunohistochemistry for each antibody combination was performed in one run to ensure staining consistency.
Quantification of Immunohistochemistry
α 1 -AR staining intensity was quantified in the epidermis, dermal blood vessels, nerve fibers in the upper dermis, and nerve fibers in large dermal nerve bundles by a blinded investigator. The epidermis was identified by morphology, blood vessels were identified by SMA staining and nerve fibers in the dermis and nerve bundles were identified using the pan-neuronal marker TUJ1. α 1 -AR staining intensity in the epidermis and nerve fibers was quantified in 7 sections per sample and averaged. Since many blood vessels were present in each skin section, α 1 -AR staining intensity in small blood vessels in the papillary dermis proximal to the epidermis was quantified as the average intensity in the smooth muscle surrounding all blood vessels in two representative images taken from one section per sample. One additional image from each α 1 -AR/SMA stained section was
collected from the deeper reticular dermis and used to quantify α 1 -AR staining intensity in the smooth muscle surrounding large blood vessels.
Images of immunostained skin sections were collected using a Nikon A1 confocal microscope. For quantification of α 1 -AR intensity, two 200X magnification confocal image stacks were collected per section; one image stack contained the papillary dermis, epidermis and dermal nerve fibers, and the other image stack was of the large dermal nerve bundles in the reticular dermis. Two 200X images of the papillary dermis and one from the reticular dermis were collected from sections stained with α 1 -AR and SMA for quantification of α 1 -AR expression on blood vessels. All confocal stacks consisted of consecutive images collected with an optical section thickness of 2 µm, and the maximum intensity projection overlay of the resulting stack was used for quantification. Special care was taken to ensure that there was no bleed-through between channels using the imaging settings chosen, and imaging settings were identical for all sections in each staining run.
Quantification of immunohistochemistry staining intensity was performed using ImageJ software (available from http://rsbweb.nih.gov.ij). The proportion of each nerve bundle occupied by nerve fibers was calculated in 4-7 nerve bundles per sample. Nerve bundles were identified using a combination of morphology and TUJ1 staining. The perimeter of each nerve bundle was manually traced around and the area was measured. An intensity threshold was applied to all TUJ1 images, which ensured that only immuno-positive TUJ1 (TUJ1 + ) pixels were included in analysis, and the proportion of TUJ1 + pixels in each nerve bundle was determined. α 1 -AR staining intensity was measured as the average pixel intensity in each area of interest.TUJ1
staining was used to identify the location of nerve fibers, which was then used as a mask on the corresponding α 1 -AR stained image, ensuring that α 1 -AR expression was only examined in those pixels also positive for TUJ1 staining. Similarly, quantification of the average α 1 -AR intensity on blood vessels was performed by creating a mask from SMA immunostaining and using that to define the
location of blood vessels in the corresponding α 1 -AR image. Quantification of α 1 -ARs in the epidermis was performed by manually drawing around the keratinocyte layer and measuring the average α 1 -AR intensity in the defined region.
α 1 -AR staining intensity was also examined in specific primary afferent neuron subpopulations:
peptidergic CGRP + neurons, non-peptidergic IB4 + neurons and myelinated NF200 + neurons. For this quantification, a co-localisation analysis was performed between each of these specific neuronal markers and TUJ1 using the "Co-localization Finder" plugin to create a mask of pixels that identified each individual neuronal population. This mask was applied to the corresponding α 1 -AR image and α 1 -AR staining intensity was then quantified in these specific neuronal populations. The proportion of nerve fibers belonging to each of these populations was quantified by expressing the number of pixels co-localized for TUJ1 and CGRP, IB4 or NF200 as a percentage of the total number of pixels labelled for TUJ1.
Statistical approach
To combine data for neural markers across multiple immunohistochemistry runs, α 1 -AR + pixel intensity within each run was expressed as a Z-score for each region of interest (nerve fibers in the papillary dermis and nerve bundles in the reticular dermis). Mean scores were then compared between the injured and contralateral limb with Wilcoxon's Signed Ranks test, and between experimental and control animals with the Mann-Whitney U test. A similar approach was used to investigate differences in α 1 -AR + pixel intensity in the epidermis and blood vessel walls, and in peptidergic, non-peptidergic and myelinated neuron populations throughout the papillary and reticular dermis. Results are reported as the mean ± standard error, and the criterion of statistical significance was p<0.05.
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Neurodegeneration after CCI
The proportion of pixels within nerve bundles labelled by the pan-neuronal marker TUJ1 was used to index the extent of neurodegeneration. There was a trend for this index to be lower in skin ipsilateral than contralateral to CCI and in comparison to skin from naive animals both in plantar and hairy skin (Table 2 ), but this trend did not achieve statistical significance.
The surviving dermal TUJ1 + fibers were then separated into peptidergic, non-peptidergic and myelinated neuron populations, and the proportions of these populations were compared across experimental groups to determine whether any of these populations were particularly vulnerable to CCI. There was a profound degeneration of NF200 + fibers in plantar skin ipsilateral to CCI ( Figure 1) ; the percentage of NF200 + pixels co-labelled for TUJ1 decreased to 6±2% of the total number of TUJ1 + pixels, which was lower than in skin contralateral to CCI (24±5%, p<0.05) and in naive animals (28± 6%, p<0.05). This degeneration was specific to NF200 + fibers as the proportions of CGRP + and IB4 + pixels remained unchanged after CCI (Table 3) . Interestingly, the degeneration of myelinated fibers was observed in plantar skin but not in hairy skin on the dorsal paw ( Figure 1 and Table 3 ).
α 1 -AR expression in skin of naïve rats
The strongest α 1 -AR expression was observed in the epidermis. α 1 -AR expression was also observed around blood vessels and in nerve fibers in the dermis and in large dermal nerve bundles. The strong α 1 -AR expression throughout the epidermis precluded observation of α 1 -ARs on intra-epidermal nerve fibers. The pattern of α 1 -AR staining was consistent with a previous study that examined α 1 -AR staining in skin from uninjured rats 6 . Figure 3A ). α 1 -AR expression was also significantly higher in TUJ1 + nerve fibers in the papillary dermis in skin ipsilateral to CCI than in contralateral skin (p<0.05) ( Figure 3B ). α 1 -AR expression was then examined in individual primary afferent subpopulations. In those nerve fibers that remained after injury, α 1 -AR expression was significantly higher on CGRP + fibers in skin ipsilateral than contralateral to CCI (p<0.05) ( Figure 4A ). α 1 -AR expression was also significantly higher in IB4 + fibers in skin ipsilateral than contralateral to CCI (p<0.05) and in comparison to skin from naive animals (p<0.05) ( Figure 4B ). Similarly, in the few remaining plantar dermal NF200 + fibers, α 1 -AR expression was higher ipsilateral than contralateral to CCI (p<0.05) ( Figure 4C ). α 1 -AR expression was significantly higher in the epidermis ipsilateral than contralateral to CCI (p<0.05) and in comparison to skin from naive animals (p<0.01) ( Figure 3C , Figure 5 ). There was no difference in α 1 -AR expression in the epidermis from skin contralateral to CCI compared to skin from naive animals. There were also no significant differences in the average α 1 -AR staining intensity in small blood vessels in the papillary dermis or large blood vessels in the reticular dermis after CCI in comparison to skin contralateral to CCI or to skin from naive animals ( Figure 6A ). α 1 -AR up-regulation was observed in plantar skin but not in hairy skin on the dorsal paw. This was an unexpected finding as both types of skin are innervated by branches of the sciatic nerve, and TUJ1 staining suggested a trend for neurodegeneration in both regions. Interestingly, in a previous study, neurons in hairy skin regenerated faster than neurons in plantar skin after sciatic nerve injury 39 ,
suggesting that there may be some inherent difference between these regions that results in different responses to injury. Our finding that NF200 + fibers were profoundly degenerated in plantar, but not hairy, skin supports this hypothesis. Extensive degeneration of myelinated fibers after CCI M A N U S C R I P T
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12 has been observed previously 4, 32, 37 . However, this is the first study to compare the degeneration in plantar and hairy skin. Why there was a difference between the two types of skin in the response to nerve injury is not yet understood, but one major difference is that the plantar skin is completely innervated by branches of the sciatic nerve whereas the medial section of the dorsal hind paw is innervated by the saphenous nerve 47 . One could speculate that the presence of uninjured saphenous nerve fibers in the hairy skin could provide a neuroprotective effect, at least during the first week after injury (the only time point examined in this study). In addition, it would be interesting to determine whether a functional process (e.g., triggered by weight-bearing on the plantar surface of the paw 11 ) influenced the response to CCI. α 1 -AR expression on large and small blood vessels was unaffected by CCI. This is interesting as blood vessels appear to have heightened sensitivity to α 1 -AR agonists after injury 21, 49, 52 . This has resulted in the hypothesis that α 1 -AR expression may be increased on blood vessels in cases of sympathetically-maintained pain and that α 1 -AR activation causes pain by inducing vasoconstriction 48 . Our results suggest that increased vascular sensitivity to α 1 -AR agonists after injury is not due to increased vascular expression of α 1 -ARs, at least in the CCI model, but instead may be a direct consequence of denervation of blood vessels and consequent loss of neuronal norepinephrine transporters 44 . This could explain both the lack of α 1 -AR up-regulation on blood vessels and increased sensitivity to α 1 -AR agonists observed after CCI.
One limitation of this study was that α 1 -AR expression was examined at only one time point, 7 days post-injury. This time point was chosen because previous studies have consistently reported the presence of mechanical and thermal hyperalgesia at this early post-injury time 5, 18, 35, 36 . However, it would be interesting in future studies to determine whether α 1 -AR up-regulation is present at later time points. In addition, it would be useful to include sham operated animals in future studies to investigate possible nonspecific effects of surgery. 
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